Statins in clinical practice

Statins in clinical practice

This review discusses statin treatment in patients with coronary heart disease (CHD), including acute coronary syndrome (ACS), based on the results of the latest clinical trials. The modern views on statin mechanisms of action are presented, including their pleiotropic effects, important for CHD and...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. S. Sivkov, S. V. Paukov, V. G. Kukes, S. I. Sivkov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2010-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	hyperlipidemia statins pleiotropic effects coronary heart disease acute coronary syndrome
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2053
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

STATINS IN ACUTE CORONARY SYNDROMES
by: A. L. Alyavi, et al.
Published: (2019-03-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Clinical effects of statins: focusing on simvastatin
by: D. M. Aronov, et al.
Published: (2009-04-01)

COMPLEX ASSESSMENT OF EFFICACY OF STATINS PRESCRIBED AT MOST BY CLINICIANS
by: A. S. Sivkov, et al.
Published: (2018-06-01)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)

Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon?
by: I. A. Latfullin, et al.
Published: (2015-12-01)

Combination of statin and ezetimibe in the post-infarction period
by: Valentin E. Oleynikov, et al.
Published: (2024-12-01)

Pharmacodynamics and clinical effectiveness of clopidogrel and atorvastin in patients with acute coronary syndrome and hyperlipidaemia
by: A. S. Sivkov, et al.
Published: (2009-08-01)

Effectiveness of lipid-lowering therapy in outpatients with coronary artery disease living in a large industrial center of Eastern Siberia
by: N. G. Gogolashvili, et al.
Published: (2022-01-01)

HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
by: A. О. Shevchenko
Published: (2016-06-01)

Statins in acute coronary syndrome
by: O. M. Drapkina
Published: (2009-10-01)

Moderate-intensity statin therapy. Efficacy and safety issues
by: N. G. Gogolashvili
Published: (2023-07-01)

Statinotherapy – the paradigm of prevention and treatment of atherosclerotic pathology (focus on atorvastatin)
by: R. G. Oganov, et al.
Published: (2006-12-01)

Aggressive statin therapy in acute coronary syndrome: therapeutic potential of atorvastatin in the daily dose of 80 mg
by: A. N. Britov
Published: (2009-12-01)

Lipid lowering and additional pleiotropic effects of statins
by: Ali Çoner, et al.
Published: (2025-04-01)

Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the levels of C-reactive protein and proinflammatory cytokines
by: A. V. Susekov, et al.
Published: (2011-12-01)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)

NON-LIPID MECHANISMS OF STATINS ACTION FOR HEART TRANSPLANT RECIPIENTS
by: А. О. Shevchenko, et al.
Published: (2013-05-01)

Ticagrelor — a legend of modern cardiology
by: S. R. Gilyarevsky
Published: (2024-10-01)

Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
by: M. G. Bubnova
Published: (2009-08-01)

ATORVASTATIN IN ACUTE AND CHRONIC KINDS OF ISCHEMIC HEART DISEASE
by: V. E. Oleynikov, et al.
Published: (2015-11-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin
by: F. Yu. Valikulova, et al.
Published: (2014-07-01)

The pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood–brain barrier protection
by: Jia-Cheng Liu, et al.
Published: (2024-12-01)

ANTIATHEROGENIC AND PLEIOTROPIC ACTIVITY OF VARIOUS DOSES OF ATORVASTATIN IN PATIENTS WITH ISCHEMIC STROKE
by: M. G. Bubnova, et al.
Published: (2013-08-01)

Choosing lipid lowering statin in risk strategy of cardiovascular event prevention
by: A. Ya. Yvleva, et al.
Published: (2007-02-01)

OSCAR Study lessons – «EpidemiOlogy and treatment of high-riSk patients in real-world ClinicAl pRactice, 2005-2006»
by: S. A. Shalnova, et al.
Published: (2007-02-01)

Establishment and validation of a risk prediction model for adverse drug reactions in patients with coronary heart disease after taking statins: a retrospective study
by: Lixiang Zhang, et al.
Published: (2025-07-01)

Acute coronary syndrome: how to reduce the residual inflammatory risk?
by: V. I. Shalnev
Published: (2020-03-01)

Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome
by: Sh. A. Mostafa, et al.
Published: (2018-11-01)

Ezetimibe potential in cardiology practice
by: A. A. Lyakishev, et al.
Published: (1970-01-01)

Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy
by: A. D. Gavrilko, et al.
Published: (2023-11-01)

The role of gene polymorphisms in individually changing of the lipid profile among patients with coronary artery disease under the influence of the statin therapy
by: I. M. Fushtey, et al.
Published: (2019-09-01)

Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
by: A. N. Britov, et al.
Published: (2011-02-01)

Oxidative stress, its role in the pathogenesis of chronic heart failure, and potential methods of correction
by: L. O. Palatkina, et al.
Published: (2012-12-01)

Myocardial infarction in patients with HIV infection: incidence, risk factors, pathogenesis, clinical performance and treatment
by: K. V. Protasov, et al.
Published: (2024-04-01)

The clinical effectiveness and safety of low/moderate-intensity statins & ezetimibe combination therapy vs. high-intensity statin monotherapy: a systematic review and meta-analysis
by: Pishoy Sydhom, et al.
Published: (2024-11-01)

Effectiveness, safety, and endothelial function effects of atorvastatin lipid-lowering therapy in coronary heart disease patients undergoing percutaneous coronary intervention
by: M. P. Mal’gina, et al.
Published: (2007-06-01)

Statin Use and the Progression of Coronary Artery Calcification in CKD: Findings From the KNOW-CKD Study
by: Jihyun Yang, et al.
Published: (2024-10-01)